Non-Human Primate (NHP) Applications in Neurological Disorders

Are you currently facing long drug development cycles, challenges in obtaining translatable preclinical data, and difficulty in modeling complex human neurological disorders? Creative Biolabs helps you accelerate drug discovery and streamline preclinical research by providing a comprehensive platform for NHP studies. We leverage advanced models and technologies to bridge the gap between basic science and clinical application, ensuring more reliable and predictable outcomes for your therapies.

Charting the Course from NHPs to Patient Advancement in Neurodegeneration Research

Bridging the gap from bench to bedside, NHP models provide essential translational data for neurological and neuropsychiatric disorders, addressing the pain points of R&D in a field where rodent models often fall short.

Get a Quote

Overview of NHP Applications

What Are Our Research Areas?

Creative Biolabs provides a robust platform for preclinical research focused on neurological disorders. The field of neurobiology faces a significant challenge in translating findings from smaller animal models to humans due to fundamental differences in brain complexity, anatomy, and behavior. Our services address this challenge by leveraging NHP models to create a more relevant and predictive preclinical environment.

CNS-Targeted Delivery & Biomarkers: Our expertise is focused on the CNS, which is critical for evaluating the delivery of advanced therapeutics to the brain and spinal cord. We also identify and validate reliable biomarkers in biofluids (e.g., CSF) and through imaging, which are essential for tracking disease progression and therapeutic response with translatable endpoints.
Models for Parkinson's, Alzheimer's, & ALS: We develop and utilize a range of NHP disease models that closely mimic the human pathological and symptomatic profiles of these neurodegenerative diseases. This allows for a more accurate assessment of a new compound's efficacy and safety, providing a higher degree of confidence than is possible with traditional models.

Why Choose Us?

Choosing Creative Biolabs' NHP platform for your neurological research provides several key advantages that are critical for success.

Genetic and Immunological Similarities: NHPs share a high degree of genetic and functional similarity with humans (up to 98.5% DNA identity), leading to more relevant and predictive preclinical data.
Clinical Translational Relevance: The neurological and behavioral similarities between NHPs and humans allow for the recapitulation of complex disease symptoms, including motor and non-motor features, that are often absent in rodent models. This enables a more accurate assessment of therapeutic efficacy.
Data Types Required for Regulatory Submissions: Data from NHP studies are often a prerequisite for regulatory submissions to agencies, particularly for advanced therapies such as gene and cell therapies. This includes crucial safety and biodistribution data.
Longitudinal Study Capability: The longer lifespan of NHPs compared to rodents allows for long-term longitudinal studies, which are essential for understanding the chronic, progressive nature of neurodegenerative diseases and for assessing the long-term effects of therapies.

A summary of disease models, brain function and imaging techniques in NHPs. (OA Literature) Fig.1 Overview of disease models, neural function, and imaging approaches in NHPs.¹

Key Applications

Creative Biolabs' NHP platform is applied to a wide range of critical research areas.

Gene and Cell Therapy Efficacy and Safety: We utilize NHPs to evaluate the efficacy and safety of advanced therapies, including AAV and lentivirus-based gene therapies and stem cell-derived treatments. Our studies focus on vector biodistribution, shedding studies, and the characterization of both on-target and off-target effects. This is particularly crucial for CNS-targeted therapies, where data on CNS penetration and neuronal tropism are essential.
Neurodegenerative Disease Modeling: We offer established and custom disease models that closely mimic human conditions. This includes the model for Parkinson's disease, as well as models for Alzheimer's disease and other neurodegenerative conditions. These models are used to investigate disease mechanisms, validate drug targets, and test the efficacy of novel compounds.
Biomarker Discovery and Validation: NHPs are invaluable for the identification and validation of biomarkers. We conduct longitudinal studies to track changes in a variety of biomarkers—from plasma and CSF to imaging-based markers—that correspond to disease progression. This helps in the selection of clinically relevant endpoints for human trials and can provide a more reliable early proof of concept for new therapies.
Behavioral and Cognitive Assessment: Given their complex neurological systems, NHPs are ideal for assessing the behavioral and cognitive impacts of neurological disorders and therapeutic interventions. Our platform includes advanced behavioral testing, including touchscreen-based cognitive assays and AI-powered video analysis, to precisely quantify motor deficits, cognitive decline, and other non-motor symptoms.

How Do Creative Biolabs Support Your Projects?

At Creative Biolabs, our comprehensive service capabilities are designed to support your entire neurological research program, from initial study design to final data delivery.

Service Capability	Corresponding Application Area
Advanced Therapy Efficacy Studies	Our services include Gene Therapy Models (AAV, Lentivirus) and Cell Therapy Models (CAR-T, iPSC-derived), with corresponding application areas in gene and cell therapy.
In Vivo Toxicology Studies	Our offerings include Advanced Therapy Safety (Gene/Cell Therapy), with a focus on safety pharmacology (CV, Resp, CNS) relevant to neurological applications.
Biomarker Profiling	For Neurological Disorders, Metabolic Diseases, Cardiovascular Diseases, and more, providing robust disease models to evaluate your therapy's effectiveness.
Custom Collection Services	We offer Donor-Matched Cohorts and Longitudinal & Repeat Sampling, providing the flexibility needed for chronic disease studies.

Translational Impact

The use of NHP models in your neurological research directly translates into a higher probability of success. Data from these studies provide a more reliable early proof of concept and help to identify potential immune responses or toxicities before they manifest in human trials. This significantly reduces the risk of IND failure, saving both time and resources. As NHP biodistribution data is often a requirement for IND submissions for gene therapy, partnering with Creative Biolabs ensures you meet regulatory standards with confidence.

Frequently Asked Questions

Q: What is the resolution and sensitivity of your neuroimaging and behavioral analysis tools?

A: We use state-of-the-art imaging equipment, including high-field MRI and PET scanners, to provide detailed morphological and functional data. Our behavioral analysis leverages AI-powered video systems to capture even subtle motor and social deficits, ensuring high-resolution data for your study.

Q: What is the turnaround time for studies, and in what format is the data delivered?

A: The turnaround time for studies varies based on complexity and duration. However, our streamlined processes and dedicated project management ensure timely execution. We provide all data in a comprehensive, integrated bioinformatics report, with raw data available in a secure, easily accessible format for your team.

Q: How do NHP models compare to humanized rodent models for neurological studies?

A: While humanized rodent models are valuable, NHPs offer a crucial advantage due to their intrinsic neuroanatomical and physiological similarities to humans. They can more accurately model the complex cognitive and behavioral aspects of neurological disorders that are difficult to replicate in rodents, providing more robust and translatable data.

Q: Can you accommodate custom genetic models or specific mutations for my project?

A: Yes, we have the capability to work with and develop custom genetic models for your research. Our team has extensive experience in applying modern gene-editing technologies to create specific models that precisely address your research question. We invite you to discuss your specific needs with our team

Contact Us

Creative Biolabs provides a world-class platform for NHP research, offering the models, technologies, and expertise needed to advance your neurological disorder programs. For more information, pricing, and to discuss your specific project needs, please reach out to our team.

Reference

Qiao, Nan et al. "Update on Nonhuman Primate Models of Brain Disease and Related Research Tools." Biomedicines vol. 11,9 2516. 12 Sep. 2023. Distributed under Open Access license CC BY 4.0, without modification. DOI: https://doi.org/10.3390/biomedicines11092516